Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients
Abstract Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system characterised by incoordination, sensory loss, weakness, changes in bladder capacity and bowel function, fatigue and cognitive impairment, creating a significant socioeconomic burden. The pathog...
Main Authors: | Naiara Celarain, Jordi Tomas-Roig |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-019-1667-1 |
Similar Items
-
Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2023-09-01) -
Steps in Multiple Sclerosis Pathogenesis - II: The Role of Biological Markers, Sodium Channels and Glutamate in Neurodegeneration
by: Ömer Faruk Aydın, et al.
Published: (2006-04-01) -
Update on inflammation, neurodegeneration and immunoregulation in MS (ORP-44)
by: Mehran Ghaffari
Published: (2023-01-01) -
The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
by: Katherine Fodder, et al.
Published: (2023-06-01) -
High-resolution DNA methylation screening of the major histocompatibility complex in multiple sclerosis
by: Qin Ma, et al.
Published: (2023-12-01)